Cargando…
Androgen Receptor-Activated Enhancers Simultaneously Regulate Oncogene TMPRSS2 and lncRNA PRCAT38 in Prostate Cancer
Prostate cancer is a common carcinoma in males, the development of which involves the androgen receptor (AR) as a key regulator. AR transactivation induces the high expression of androgen-regulated genes, including transmembrane protease serine 2 (TMPRSS2) and long noncoding RNA prostate cancer-asso...
Autores principales: | Chen, Zikai, Song, Xuhong, Li, Qidong, Xie, Lingzhu, Guo, Tangfei, Su, Ting, Tang, Chang, Chang, Xiaolan, Liang, Bin, Huang, Dongyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721761/ https://www.ncbi.nlm.nih.gov/pubmed/31405024 http://dx.doi.org/10.3390/cells8080864 |
Ejemplares similares
-
Aberrant activation of CYR61 enhancers in colorectal cancer development
por: Xie, Lingzhu, et al.
Publicado: (2019) -
LncRNA-RMRP Acts as an Oncogene in Lung Cancer
por: Meng, Qingjun, et al.
Publicado: (2016) -
Androgen-Responsive Oncogenic lncRNA RP11-1023L17.1 Enhances c-Myc Protein Stability in Prostate Cancer
por: Huang, Wenhua, et al.
Publicado: (2022) -
Survival-Related lncRNA Landscape Analysis Identifies LINC01614 as an Oncogenic lncRNA in Gastric Cancer
por: Wu, Huijie, et al.
Publicado: (2021) -
FEZF1-AS1 functions as an oncogenic lncRNA in retinoblastoma
por: Quan, Lian-Jiao, et al.
Publicado: (2019)